IS4244A - Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra - Google Patents

Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra

Info

Publication number
IS4244A
IS4244A IS4244A IS4244A IS4244A IS 4244 A IS4244 A IS 4244A IS 4244 A IS4244 A IS 4244A IS 4244 A IS4244 A IS 4244A IS 4244 A IS4244 A IS 4244A
Authority
IS
Iceland
Prior art keywords
producing
indoline derivatives
indoline
derivatives
Prior art date
Application number
IS4244A
Other languages
English (en)
Inventor
Charles North Peter
Clive Carter Malcolm
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4244A publication Critical patent/IS4244A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4244A 1993-12-22 1994-12-16 Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra IS4244A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Publications (1)

Publication Number Publication Date
IS4244A true IS4244A (is) 1995-06-23

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4244A IS4244A (is) 1993-12-22 1994-12-16 Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra

Country Status (15)

Country Link
US (1) US5633276A (is)
EP (1) EP0736028A1 (is)
JP (1) JPH09507057A (is)
AP (1) AP535A (is)
AU (1) AU684877B2 (is)
CA (1) CA2179402A1 (is)
CO (1) CO4340623A1 (is)
GB (1) GB9326192D0 (is)
IL (1) IL112097A (is)
IS (1) IS4244A (is)
MY (1) MY131641A (is)
SV (1) SV1994000083A (is)
TW (1) TW291479B (is)
WO (1) WO1995017405A1 (is)
ZA (1) ZA9410056B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
EP0885210B2 (en) * 1996-03-08 2008-06-18 Takeda Pharmaceutical Company Limited Tricylic compounds having binding affinity for melatonin receptors, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
ZA9711051B (en) * 1996-12-10 1999-06-09 Bristol Myers Squibb Co Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents
WO1998038991A1 (en) * 1997-03-05 1998-09-11 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
CA2334299A1 (en) 1998-06-05 1999-12-09 Pierre Dextraze Heterocyclic cis cyclopropane derivatives as melatonergic agents
EP1189900B1 (en) 1999-06-30 2004-01-14 Bristol-Myers Squibb Company Heterocyclic aminopyrrolidine derivatives as melatonergic agents
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
CA2382418A1 (en) 1999-08-20 2001-03-01 Shigenori Ohkawa Dihydrobenzofuran derivatives, process for preparing thereof and agents
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
DK1268482T3 (da) * 2000-03-17 2003-12-22 Alcon Inc Pyranoindoler til behandling af glaukom
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
US6743448B2 (en) * 2000-12-11 2004-06-01 Abraham H. Kryger Topical testosterone formulations and associated methods
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
CA2644181A1 (en) * 2006-03-20 2007-09-27 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for irritable bowel syndrome
ATE548371T1 (de) 2006-12-08 2012-03-15 Takeda Pharmaceutical Tricyclische verbindung und deren medizinische verwendung
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
JP2011529477A (ja) * 2008-07-30 2011-12-08 フエルレル インターナショナル,ソシエダッド アノニマ 1,6−ジヒドロ−2h−3−オキサ−6−アザ−as−インダセン化合物
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect

Also Published As

Publication number Publication date
WO1995017405A1 (en) 1995-06-29
CA2179402A1 (en) 1995-06-29
JPH09507057A (ja) 1997-07-15
ZA9410056B (en) 1995-10-18
AP9400706A0 (en) 1995-01-31
GB9326192D0 (en) 1994-02-23
AU684877B2 (en) 1998-01-08
US5633276A (en) 1997-05-27
CO4340623A1 (es) 1996-07-30
EP0736028A1 (en) 1996-10-09
SV1994000083A (es) 1995-07-24
MY131641A (en) 2007-08-30
TW291479B (is) 1996-11-21
IL112097A0 (en) 1995-03-15
AU1274395A (en) 1995-07-10
AP535A (en) 1996-09-16
IL112097A (en) 1998-06-15

Similar Documents

Publication Publication Date Title
IS4244A (is) Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
IS4219A (is) Aðferð til framleiðslu á Indole afleiðum
IS3994A (is) Hliðstæð aðferð til framleiðslu á indole afleiðum
IS4205A (is) Hliðstæð aðferð til framleiðslu á andróstenón afleiðu og milliefni til notkunar með aðferðinni
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
DK0874733T3 (da) Syntetisk laminatstruktur og fremgangsmåde til fremstilling deraf
DK1095941T3 (da) Fremgangsmåde og krystalformer for 2-methyl-thieno-benzodiazepin
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
NO20003183D0 (no) FremgangsmÕte og anordning for fremstilling av en forkortet cellulosestruktur
NO950205D0 (no) Framgangsmåte og anordning for framstilling av emballasje
IS1609B (is) Hliðstæð aðferð til framleiðslu á benzofuran afleiðum og milliefni til notkunar við aðferðina
NO972578D0 (no) Fremgangsmåte og anordning for forsegling
IS3555A7 (is) Pyrrol-afleiður og aðferð til framleiðslu þeirra
NO931040L (no) Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
NO944891L (no) Fremgangsmåte og anordning for avviksboring
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
NO174334C (no) Fremgangsmåte og innretning til fremstilling av fiberplater
IS4854A (is) Aðferð og búnaður til þess að framleiða staðgengil rauðra blóðkorna
NO994599L (no) Anordning og fremgangsmåte for prosodigenering av visuell syntese
NO179526C (no) Fremgangsmåte og anordning for sammenföyning
NO941110D0 (no) Fremgangsmåte og apparat for fremstilling av bioproteiner
DK288790D0 (da) Metode og indretning til pressestoebning
NO301652B1 (no) Fremgangsmåte og innretning for oppberedning av blandinger av lettmetall
IS4055A (is) Aðferð til framleiðslu á Lactam afleiðum